View
216
Download
1
Category
Preview:
Citation preview
www.americanleaders.com
EXPERT SPEAKER PANEL
CHAIRPERSON: FRANK MAKOSIEj Covance Executive Director, Operational Strategy and Planning
USMAN IqbAL, MD, MPH, MbA Sr. Medical Affairs Leader- ING, Global Medical Affairs AstraZeneca
KAREN GRAHAM, PMP Senior Director, Project Management, Oncology Portfolio Leader Covance
FRANK MAKOSIEj Executive Director, Operational Strategy and Planning Covance
SANjEEv RAMAbHADRAN Director, Project and Portfolio Management Daiichi Sankyo Pharma Development
SEAN (YONG) XUE Director, Portfolio Management – Biologics Dr. Reddy’s Laboratories
RICHARD SONNENbLICK CEO Enrich
jULIO GAGNE Executive Program Director ImmunoGen
SULTAN M. AZIZ Senior Director, Head of Capacity Management janssen Pharmaceutical Companies of johnson & johnson
DAvID TOwNSON Head, Program Office, Cell and Gene Therapies Novartis
PETER HEINRICH President & CEO PDware
CHRISTOPHER bECK VP Schedule and Resource Decision Analytics Shire
MATT MCLEOD Senior Director, Development Team Program Lead Tesaro
GRANT MORGAN SVP Portfolio Planning, Systems & Analytics bTG International
MARK MLYNARCZYK Senior Director, Portfolio Operations, Strategy & Management MedImmune
8th Project and Portfolio
Management for Pharma
& biotech
Leveraging the Catalysts of Portfolio Success
October 6 - 7, 2015 Hyatt Regency boston
Post-show report
8th Project and Portfolio Management for Pharma & biotechAnalyzing Portfolio Risk Throughout the Project Lifecycle
October 6 - 7, 2015 | boston, MA
Table of contents
Page 2 Table of contents
Page 3 About the 8th annual
Page 4 Key sessions of the conference + delegate breakdown
Page 5 Sponsor and delegate list
‘The sharing of information across companies is key for the long-term health of the industry. This conference allows for a litmus test for your own company.’
vincent AgrestoSenior Project Associate, Program Management Systems
& Operations Regeneron
‘An incredibly insightful event and collection of industry thought leaders.’
Matt Killeen, PhD.,Associate Director, Portfolio Strategy and Competitive
IntelligencebioMarin
‘The American Leaders meeting provided attendees with an excellent blend of actionable ideas that can be applied across many types and sizes of organizations.’
David TownsonExecutive Director, Global Program Team Director and
Program Management Site HeadNovartis Oncology
‘Interesting cross-section of topics and stakeholders around the industry!’
Sanjeev RamabhadranDirector, Project & Portfolio Management Global Project
Management & LeadershipDaiichi Sankyo, Inc.
‘The conference was initimate and ultimately informative. I, personally, have several “ah-ha” moments that I will take back to my company.’
Grant MorganSenior Vice President, Portfolio Panning, Systems &
AnalyticsbTG International
About the 8th AnnualFor the eighth time, senior executives from the pharma and biotech industries gathered in October 2015 at the Hyatt Regency in downtown Boston for one of the longest-running American Leaders conferences. The speaker panel 8th Annual Project and Portfolio Management for Pharma and Biotech, chaired by Covance’s Executive Director, Frank Makosiej, featured senior executives from the biggest names in the industry: including companies such as AstraZeneca, Novartis or Daiichi Sankyo. The two-day program was split into interactive sessions, providing delegates with practical solutions to the biggest issues in today’s pharma PPM. Special focus was placed on strategic alignment thanks to the “Building an Action Plan” feature. After each session, delegates were dedicated space to work on implementing the newly-gained knowledge in their companies and to discuss strengths, weaknesses and limitations.During the two conference days, delegates discussed their opinions and shared their experience on portfolio risk management, decision-making, prescriptive modelling and data analysis for pharma portfolios, among other topics. When asked about their opinions on the event, this is what the attendees had to say:
The venue:This luxury Boston hotel features 30,000 square feet of elegant and flexible function space with innovative audiovisual equipment, hotel-wide Wi-Fi access and creative catering menus. With a combination of award-winning service and custom amenities, Hyatt Regency Boston is the premier hotel for business travelers.
8th Project and Portfolio Management for Pharma & biotechAnalyzing Portfolio Risk Throughout the Project Lifecycle
October 6 - 7, 2015 | boston, MA
Key sessions of the 8th Annual
There were several hot topics presented and discussed in detail at the 8th Annual Project & Portfolio Management for Pharma and Biotech. Here are some of the sessions that were met with the best feedback from this year’s delegates:
• Daiichi Sankyo’s case study on examining progression of a project’s viability at each stage of the life cycle
• Novartis presented their own tested methodology on employing micro-funding strategies to increase portfolio flexibility
• AstraZeneca illustrated evidence-based approaches to manage portfolio risk and prioritization in their breakout session
• Roundtable discussion on portfolio and resource planning integration
• Spotlight session on portfolio planning and execution
• Case study on predictive and prescriptive modeling to help drive portfolio optimization, presented by janssen & janssen
• Dedicated networking sessions with project, portfolio and resource management decision makers
job title distribution:
68% Directors/General Managers
25% Managers/Heads of Departments
7% Specialists
8th Project and Portfolio Management for Pharma & biotechAnalyzing Portfolio Risk Throughout the Project Lifecycle
October 6 - 7, 2015 | boston, MA
MEET OUR PARTNERS
SILvER SPONSORS
PDware™ is a provider of resource planning and portfolio management software. ResourceFirst™, our flagship PPM product, helps organizations improve operations through a combination of resource forecasting, capacity planning, time tracking, status reporting and financial analysis. ResourceFirst is available for cloud and on-premise installations, providing first-line managers, executives, PMOs and EPPMOs the agility to meet fluctuating work priorities, capacity and demand. PDWare customers include Medtronic, BD, Cablevision, Regeneron, SIG, Motorola,
Philips, Stryker and Tektronix.
Enrich was born out of a restless desire to help companies do more—create more game-changing technology, develop more life-saving drugs, find more opportunity. For our clients, we build transparency into the decisions that drive their business forward. The Enrich Analytics Platform (EAP) provides the enterprise computing power; our high-touch, one-on-one approach builds the custom solutions that empower clients to make strategic business
decisions—and follow through on them.
MEDIA PARTNERS
8th Project and Portfolio Management for Pharma & biotechAnalyzing Portfolio Risk Throughout the Project Lifecycle
October 6 - 7, 2015 | boston, MA
8th Project and Portfolio Management for Pharma & biotechAnalyzing Portfolio Risk Throughout the Project Lifecycle
October 6 - 7, 2015 | boston, MA
8th Project and Portfolio Management for Pharma & biotechAnalyzing Portfolio Risk Throughout the Project Lifecycle
October 6 - 7, 2015 | boston, MA
Company jobtitle Country
AbbVie Director, Project Office USA
AbbVie Assistant Director, Planning & Portfolio Support USA
Abbott Diagnostics Director, Portfolio Management USA
Acetylon Pharmaceuticals Senior Director, Program Management USA
Adamas Pharmaceuticals Senior Director USA
Adamas Pharmaceuticals Vice President USA
Aegerion Pharmaceuticals Director, Program Management USA
Aegerion Pharmaceuticals Senior Director, Program Management USA
Alexion Pharmaceuticals Project Manager USA
Alexion Pharmaceuticals Project Planner USA
Alexion Pharmaceuticals Senior Director USA
Alkermes Senior Financial Analyst Ireland
Alkermes Senior Director, Strategic Planning & Portfolio Management Ireland
Allergan Manager, Portfolio Analysis USA
Allergan Business Analytics Manager USA
Amgen Manager, Strategic Planning & Operations USA
Amgen Director, Pipeline Strategy & Portfolio Management USA
Aptalis Pharma Senior Director, Project Management USA
AstraZeneca Head, Business Operations – Neuroscience USA
Baxalta Senior Director, Business Operations – Global Project Management USA
BIND Therapeutics Project & Portfolio Professional USA
BioMarin Pharmaceuticals Senior Director USA
BioMarin Pharmaceuticals Senior Director USA
BioMarin Pharmaceuticals Associate Director USA
BioMarin Pharmaceuticals Assistant Director, Portfolio Strategy USA
Boston Scientific Senior Manager, Corporate Portfolio USA
CNRC-IRB Director Canada
Covance Director, Portfolio Management USA
Covance Senior Director, Portfolio Management USA
Covidien Manager, Strategy & Portfolio USA
Eisai Executive Director, Global Oncology Business Unit USA
Eli Lilly Advisor, Portfolio Planning USA
Emergent BioSolutions Senior Director, Scientific Services USA
Eureka Therapeutics Head USA
Genetech Global Manager, PMO, Producer, Portfolio Management USA
Genetech Cross Portfolio Governance USA
Genetech Manager, Portfolio Management, USA Oncology Pipeline & Portfolio Planning
Genetech Ophthalmology Franchise Lead, Pipeline & Portfolio Planning USA
Genzyme Manager, Portfolio & Development Operations USA
Gilead Director, Planning & Portfolio Analysis USA
Gilead Associate Director USA
Green Cross Corporation Deputy General Manager South Korea
Green Cross Corporation Manager South Korea
Grifols Head, Project Management USA
Helsinn Therapeutics Manager, Project Management & Planning USA
Impax Laboratories Senior Director, Portfolio Management USA
Impax Laboratories Associate Director, Strategic Portfolio Management USA
Integrated Project Management Business Development Executive USA
Jazz Pharmaceuticals Senior Director, Project Management USA
Johnson & Johnson Innovation Director USA
Johnson & Johnson Innovation Global Portfolio Manager USA
Juno Therapeutics Program Manager USA
Juno Therapeutics Senior Director, Program/Alliance USA
Life Technologies/Thermo Fisher Head, Program Management Office USA
MedImmune Senior Project Manager USA
Merck Associate Director USA
Millenium Pharmaceuticals, Portfolio Manager USA The Takeda Oncology Company
Millenium Pharmaceuticals, Director, Drug Development Manager USA The Takeda Oncology Company
Novartis Executive Director USA
NPS Pharmaceuticals Director, Project Management USA
8th Project and Portfolio Management for Pharma & biotechAnalyzing Portfolio Risk Throughout the Project Lifecycle
October 6 - 7, 2015 | boston, MA
NPS Pharmaceuticals Senior Director, Project Management USA
OncoMed Pharmaceutical CMC Team Leader USA
Onyx Pharmaceuticals Senior Manager USA
OvaScience Associate Manager, Program Management USA
Perrigo Director USA
Perrigo Director, Stage Gate USA
Regeneron Pharmaceuticals Director USA
Regeneron Pharmaceuticals Senior Project Associate USA
Roche Head, Strategy & Portfolio, Switzerland Pharma Reserach & Early Development
SciClone Pharmaceuticals Assistant Project Manager USA
Seattle Genetics Inc. Senior Director, Programs & Alliance Management USA
Shire Pharmaceuticals Associate Director USA
Smith and Nephew Senior Project Manager USA
Sunovion Pharmaceuticals Associate Director USA
Sunovion Pharmaceuticals Director USA
Sunovion Pharmaceuticals Senior Director USA
Takeda Pharmaceuticals Associate Director, Portfolio Management USA
Takeda Pharmaceuticals Associate Director, Global Project Management USA & Drug Development Management
Taris Biomedical Director, Program Management USA
Teva Pharmaceuticals Group General Manager USA
Vertex Pharmaceuticals R&D Program Manager USA
Vertex Pharmaceuticals Director USA
X-gen Director USA
XOMA Ltd. Senior Project Manager USA
XOMA Ltd. Associate Director USA
XOMA Ltd. Director USA
XOMA Ltd. Associate Director, Project & Alliance Management USA
8th Project and Portfolio Management for Pharma & biotechAnalyzing Portfolio Risk Throughout the Project Lifecycle
October 6 - 7, 2015 | boston, MA
Recommended